{"688758":{"#nid":"688758","#data":{"type":"news","title":"Target the Tumor. Spare the Body.","body":[{"value":"\u003Cp\u003EGeorgia Tech researcher Nick Housley is developing a drug\u2011delivery system designed to send cancer treatments directly to tumors while minimizing damage to healthy tissue. His team\u2019s approach uses self\u2011assembling nanohydrogels (SANGs) that circulate through the body, remain inactive in healthy environments, and release their drug payload only when they encounter the unique chemical conditions created by tumors. This \u201ccancer\u2011agnostic\u201d strategy avoids the pitfalls of traditional targeted therapies, which can lose effectiveness as tumors evolve, and aims to reduce the harsh side effects patients often endure. Early preclinical results show that the nanohydrogels successfully concentrated drugs at tumor sites, and Housley\u2019s team is now preparing for broader testing to move the technology toward clinical trials.\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/research.gatech.edu\/node\/45127\u0022\u003E\u003Cstrong\u003ERead more \u00bb\u003C\/strong\u003E\u003C\/a\u003E\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":[{"value":"A Georgia Tech researcher is working to send cancer drugs to tumors \u2014 and avoid healthy tissue."}],"field_summary":[{"value":"\u003Cp\u003EGeorgia Tech researcher Nick Housley is developing a drug\u2011delivery system designed to send cancer treatments directly to tumors while minimizing damage to healthy tissue. Early preclinical results show that the nanohydrogels successfully concentrated drugs at tumor sites, and Housley\u2019s team is now preparing for broader testing to move the technology toward clinical trials.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Housley and his team are developing self\u2011assembling nanohydrogels that deliver cancer drugs only when they reach tumor\u2011specific conditions, aiming to reduce side effects and make treatment more precise across multiple cancer types."}],"uid":"27255","created_gmt":"2026-03-05 23:19:22","changed_gmt":"2026-03-20 13:02:20","author":"Josie Giles","boilerplate_text":"","field_publication":"","field_article_url":"","location":"Atlanta, GA","dateline":{"date":"2026-03-06T00:00:00-05:00","iso_date":"2026-03-06T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"679537":{"id":"679537","type":"image","title":"20260226-Cancer-Delivery-System-Story-6.jpg","body":"\u003Cdiv\u003E\u003Cdiv\u003E\u003Cp\u003ENick Housley\u2019s latest advancement is a drug\u2011delivery system called SANGs, short for \u201cself\u2011assembling nanohydrogels.\u201d As these nanohydrogels move through the body, they keep the cancer\u2011fighting drug contained, passing through healthy tissue without releasing medicine. When they encounter the unique conditions created by a tumor, they remain in that environment and release the drug precisely where it\u2019s needed.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E","created":"1772752775","gmt_created":"2026-03-05 23:19:35","changed":"1772752775","gmt_changed":"2026-03-05 23:19:35","alt":"A person wearing a blue lab coat stands with arms crossed in a laboratory filled with shelves of scientific equipment, supplies, and a refrigerator unit in the background.","file":{"fid":"263710","name":"20260226-Cancer-Delivery-System-Story-6.jpg","image_path":"\/sites\/default\/files\/2026\/03\/05\/20260226-Cancer-Delivery-System-Story-6.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/2026\/03\/05\/20260226-Cancer-Delivery-System-Story-6.jpg","mime":"image\/jpeg","size":14461101,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/2026\/03\/05\/20260226-Cancer-Delivery-System-Story-6.jpg?itok=hcwCBuaP"}}},"media_ids":["679537"],"groups":[{"id":"1278","name":"College of Sciences"},{"id":"66220","name":"Neuro"},{"id":"1188","name":"Research Horizons"},{"id":"1275","name":"School of Biological Sciences"}],"categories":[],"keywords":[{"id":"172970","name":"go-neuro"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"},{"id":"193658","name":"Commercialization"},{"id":"193652","name":"Matter and Systems"},{"id":"39501","name":"People and Technology"}],"news_room_topics":[{"id":"71891","name":"Health and Medicine"}],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}